Home › Compare › TRYPF vs VICI

TRYPF vs VICI: Dividend Comparison 2026

TRYPF yields 3558.72% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRYPF wins by $2329727088830.52M in total portfolio value
10 years
TRYPF
TRYPF
● Live price
3558.72%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2329727088831.49M
Annual income
$2,207,692,570,087,591,000.00
Full TRYPF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — TRYPF vs VICI

📍 TRYPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRYPFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRYPF + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TRYPF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRYPF
Annual income on $10K today (after 15% tax)
$302,491.10/yr
After 10yr DRIP, annual income (after tax)
$1,876,538,684,574,452,200.00/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, TRYPF beats the other by $1,876,538,684,573,935,900.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRYPF + VICI for your $10,000?

TRYPF: 50%VICI: 50%
100% VICI50/50100% TRYPF
Portfolio after 10yr
$1164863544416.23M
Annual income
$1,103,846,285,044,099,200.00/yr
Blended yield
94.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

TRYPF
No analyst data
Altman Z
-3902.6
Piotroski
1/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRYPF buys
0
VICI buys
0
No recent congressional trades found for TRYPF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRYPFVICI
Forward yield3558.72% ✓6.52%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$2329727088831.49M ✓$966.2K
Annual income after 10y$2,207,692,570,087,591,000.00 ✓$607,376.13
Total dividends collected$2321360563920.16M ✓$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TRYPF vs VICI ($10,000, DRIP)

YearTRYPF PortfolioTRYPF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$366,572$355,871.89$11,361$941.49+$355.2K → TRYPF
2$12,584,066$12,191,834.44$13,320$1,481.32+$12.57M → TRYPF
3$404,618,364$391,153,413.41$16,284$2,405.01+$404.60M → TRYPF
4$12,187,002,569$11,754,060,918.87$21,040$4,071.78+$12186.98M → TRYPF
5$343,908,630,433$330,868,537,684.68$29,209$7,285.49+$343908.60M → TRYPF
6$9,094,035,633,286$8,726,053,398,722.06$44,443$14,006.51+$9094035.59M → TRYPF
7$225,379,725,862,498$215,649,107,734,881.84$75,822$29,512.55+$225379725.79M → TRYPF
8$5,236,002,075,601,348$4,994,845,768,928,476.00$148,733$69,726.75+$5236002075.45M → TRYPF
9$114,050,952,097,100,620$108,448,429,876,207,180.00$344,394$189,413.75+$114050952096.76M → TRYPF
10$2,329,727,088,831,488,000$2,207,692,570,087,591,000.00$966,234$607,376.13+$2329727088830.52M → TRYPF

TRYPF vs VICI: Complete Analysis 2026

TRYPF — Stock

Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. The company has an agreement with the Calvert Labs to design and execute exploratory studies related to psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and training for the psychotherapeutic portion of Tryp's clinical trial activities. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was incorporated in 2019 and is based in Kelowna, Canada.

Full TRYPF Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this TRYPF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRYPF vs SCHDTRYPF vs JEPITRYPF vs OTRYPF vs KOTRYPF vs MAINTRYPF vs NNNTRYPF vs EPRTTRYPF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.